REGENERON PHARMACEUTICALS, INC. Insider Trading for December 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for December 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 386.90 | 257,850 | 99,762,165 | 422,762 | 680.6 K to 422.8 K (-37.89 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 378.98 | 139,474 | 52,857,857 | 139,474 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 21.92 | 250,000 | 5,480,000 | 0 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 385.08 | 121,586 | 46,820,337 | 271,593 | 393.2 K to 271.6 K (-30.92 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 385.08 | 14,230 | 5,479,688 | 393,179 | 407.4 K to 393.2 K (-3.49 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 21.92 | 250,000 | 5,480,000 | 407,409 | 157.4 K to 407.4 K (+158.82 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Option Exercise | A | 378.98 | 139,474 | 52,857,857 | 139,474 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Option Exercise | M | 21.92 | 195,438 | 4,284,001 | 0 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 385.08 | 95,050 | 36,601,854 | 680,612 | 775.7 K to 680.6 K (-12.25 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Payment of Exercise | F | 385.08 | 11,124 | 4,283,630 | 775,662 | 786.8 K to 775.7 K (-1.41 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President & CSO | Buy | M | 21.92 | 195,438 | 4,284,001 | 786,786 | 591.3 K to 786.8 K (+33.05 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 378.98 | 23,337 | 8,844,256 | 23,337 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | A | 378.98 | 12,300 | 4,661,454 | 12,300 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 378.98 | 50,000 | 18,949,000 | 50,000 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 378.98 | 74,390 | 28,192,322 | 74,390 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.92 | 153,969 | 3,375,000 | 0 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 91 | 0 | 149,717 | 149.8 K to 149.7 K (-0.06 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 477 | 0 | 149,808 | 150.3 K to 149.8 K (-0.32 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 383.29 | 74,860 | 28,693,089 | 399,847 | 474.7 K to 399.8 K (-15.77 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 383.29 | 8,805 | 3,374,868 | 474,707 | 483.5 K to 474.7 K (-1.82 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.92 | 153,969 | 3,375,000 | 483,512 | 329.5 K to 483.5 K (+46.72 %) |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 378.98 | 50,000 | 18,949,000 | 50,000 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | A | 378.98 | 32,300 | 12,241,054 | 32,300 | |
Dec 13 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 378.98 | 23,337 | 8,844,256 | 23,337 |